Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Crossref DOI link: https://doi.org/10.1007/s13300-023-01408-2
Published Online: 2023-04-30
Published Print: 2023-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, Marc
Berry, Sasha
Malkin, Samuel J. P.
Hunt, Barnaby
Sharma, Abheet
Text and Data Mining valid from 2023-04-30
Version of Record valid from 2023-04-30
Article History
Received: 14 February 2023
Accepted: 12 April 2023
First Online: 30 April 2023